Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-445-9519
Fax+1 216-445-2226
Dr. Rachitskaya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
B Palmer Eye Institute - A B Leach EyeChief Residency, Chief Resident & Co-Director of Ocular Trauma, 2013 - 2014
University of Miami Hospital and ClinicsFellowship, Surgical Retina and Vitreous, 2012 - 2014
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2009 - 2012
George Washington UniversityResidency, Internal Medicine, 2008 - 2009
Case Western Reserve University School of MedicineClass of 2008
Certifications & Licensure
OH State Medical License 2014 - 2026
FL State Medical License 2012 - 2022
DC State Medical License 2008 - 2009
VA State Medical License 2008 - 2009
American Board of Ophthalmology Ophthalmology
Clinical Trials
- Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis Start of enrollment: 2018 Jan 30
Publications & Presentations
PubMed
- Glucagon-Like Peptide-1 Receptor Agonist Use and Age-Related Macular Degeneration-Where Do We Stand?Katherine E Talcott, Aleksandra V Rachitskaya, Rishi P Singh
JAMA Ophthalmology. 2025-10-23 - Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema.Gabriel Castilho S Barbosa, Suraj Bala, Nitesh Mohan, Sunil K Srivastava, Peter K Kaiser
Journal of Vitreoretinal Diseases. 2025-10-04 - Long-Term Outcomes and Patient Experiences With the Argus II Retinal Prosthesis System.Jonathan D Shirian, Alex Yuan, Aleksandra Rachitskaya
Journal of Vitreoretinal Diseases. 2025-10-04
Authored Content
- Invasive Eye Operations Should Be Left up to Surgeons. Ohio Bill a Dangerous to Your SightJune 2024
- Argus II Retinal Prosthesis Complication Profile Pre- and Post-FDA ApprovalAugust 2018
Press Mentions
- A Call for Holistic CareSeptember 15th, 2025
GLP-1 Agonists May Lower Risk of Age-Related Macular DegenerationJune 11th, 2025- The Port Delivery System Shows Long-Term Potential for Multiple DiseasesJuly 30th, 2024
- Join now to see all
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
